Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Discovery of FR115092: a novel antinephritic agent
T Ogino, K Tsuji, T Tojo, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|
November 1, 1988
[The sensitized rate of preformed antibodies in the candidate of renal transplant recipient]
F Nishigaki, K Yoda, T Takahashi, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
Y Naoe, M Inami, S Matsumoto, et al.
Japanese Journal of Cancer Research : Gann
|
December 16, 1998
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro
Y Naoe, M Inami, S Takagaki, et al.
The Journal of Antibiotics
|
August 1, 1995
A new aromatase inhibitor, FR901537. II. Pharmacological and antitumor effects
N Oohata, I Kawamura, E Lacey, et al.
Biological & Pharmaceutical Bulletin
|
February 1, 1994
The induction of interleukin-6 (IL-6) and colony-stimulating factors (CSFs) by FK565 and its thrombopoietic activity following in vivo administration
M Maeda, S Suzuki, K Ohtsuka, et al.
Anticancer Research
|
May 6, 1998
Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice
N Yamamoto, I Kawamura, F Nishigaki, et al.
Arzneimittel-Forschung
|
August 1, 1989
Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma
I Kawamura, T Mizota, S Mukumoto, et al.
Cancer Research
|
July 15, 1987
Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity
T Manda, K Shimomura, S Mukumoto, et al.
Cancer Research
|
March 1, 1988
Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice
K Shimomura, T Manda, S Mukumoto, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Discovery of FR115092: a novel antinephritic agent
T Ogino, K Tsuji, T Tojo, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|
November 1, 1988
[The sensitized rate of preformed antibodies in the candidate of renal transplant recipient]
F Nishigaki, K Yoda, T Takahashi, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
Y Naoe, M Inami, S Matsumoto, et al.
Japanese Journal of Cancer Research : Gann
|
December 16, 1998
Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro
Y Naoe, M Inami, S Takagaki, et al.
The Journal of Antibiotics
|
August 1, 1995
A new aromatase inhibitor, FR901537. II. Pharmacological and antitumor effects
N Oohata, I Kawamura, E Lacey, et al.
Biological & Pharmaceutical Bulletin
|
February 1, 1994
The induction of interleukin-6 (IL-6) and colony-stimulating factors (CSFs) by FK565 and its thrombopoietic activity following in vivo administration
M Maeda, S Suzuki, K Ohtsuka, et al.
Anticancer Research
|
May 6, 1998
Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice
N Yamamoto, I Kawamura, F Nishigaki, et al.
Arzneimittel-Forschung
|
August 1, 1989
Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma
I Kawamura, T Mizota, S Mukumoto, et al.
Cancer Research
|
July 15, 1987
Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity
T Manda, K Shimomura, S Mukumoto, et al.
Cancer Research
|
March 1, 1988
Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice
K Shimomura, T Manda, S Mukumoto, et al.
Page
of 4